Mu myaka yashize, uruganda rwo mu isuzuma rya vitro (IVD) rwateye imbere vuba.Nk’uko imibare yashyizwe ahagaragara na Evaluate MedTech ibigaragaza, kuva mu 2014 kugeza 2017, igipimo cyo kugurisha ku isi ku isi inganda za IVD cyiyongereye uko umwaka utashye, kiva kuri miliyari 49 z'amadolari ya Amerika muri 2014 kigera kuri miliyari 52 z'amadorari muri 2017, hamwe n’ubwiyongere bwa buri mwaka bwa 1.8%;muri 2024, biteganijwe ko igipimo cyo kugurisha isoko kizagera kuri miliyari 79 z'amadolari miliyoni 600, kuva 2017 kugeza 2024 Iterambere ry’ubwiyongere bw’umwaka ryageze kuri 6.1%.Ni muri urwo rwego, ubuvuzi bukenewe bwiyongera hamwe n’inganda zikoreshwa mu nganda nazo zitanga ibisabwa bishya ku bicuruzwa n’ikoranabuhanga bya IVD.Nyuma yimyaka icumi yiterambere ryigenga rya "Lica yumucyo uterwa na chemiluminescence", nkuburyo bushya bwa chemiluminescent immunoassay, kwisuzumisha Kemei mu buryo bwa gihanga hifashishijwe uburyo bwo kuvura abantu bahuje ibitsina hamwe n’uduce twinshi twa tekinoroji, bitanga igisubizo gishya kuri laboratoire nyinshi z’amavuriro.Nk’uko imibare rusange ibigaragaza, mu rwego rwa chemiluminescence immunodiagnose mu Bushinwa, ibisubizo byiza by’ahantu byagezweho mu rwego rwa immunodiagnose yo hagati ndetse no mu rwego rwo hasi.Nyamara, ku isoko ry’imiti yo mu rwego rwo hejuru mu Bushinwa, inganda zitumizwa mu mahanga ziracyafite hejuru ya 80% by’imigabane ku isoko.Muri bo, Abbott, Roche, Beckman na Siemens bangana na 70% by'imigabane ku isoko.Icyakora, hamwe n’iterambere ry’imikoreshereze y’ubuvuzi mu Bushinwa, guteza imbere ivugurura ry’ubuvuzi, no gushyigikirwa cyane na politiki y’inganda z’igihugu, twibanze ku iterambere ry’imyororokere ya vitro, kandi twizera ko tuzafatanya nawe.